Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic Cardiomyopathy

Completed

• Conditions: Familial Hypertrophic Cardiomyopathy

• Registration Number: NCT01792960
• Lead Sponsor: Yonsei University

Brief Summary

Set the Korean Familial Hypertrophic Cardiomyopathy (KFHC) registry to study the prevalence of gene mutations in Korean patients with familial hypertrophic cardiomyopathy

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2013-02
• Study First Submitted: 2013-02-07
• Study First Submitted QC: 2013-02-13
• Study First Posted: 2013-02-15
• Primary Completion: 2013-08
• Study Completion: 2013-08
• Status Verified: 2014-02
• Last Update Submitted: 2014-02-17
• Last Update Posted: 2014-02-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 99

Inclusion Criteria

1. left ventricular maximal wall thickness ≥ 15mm on echocardiography
2. hypertrophic cardiomyopathy patients' relatives

Read More

Exclusion Criteria

1. other cardiomyopathy or systemic disease (e.g. fabry disease, danon disease, glycogen storage disease)
2. who deny the study entrance, especially in patients' relatives

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1) DNA analysis	1 year	1) Identify susceptible genes for familial hypertrophic cardiomyopathy in Korean

Secondary Outcome Measures

Name	Time	Method
2) Prognosis of familial hypertrophic cariomyopathy	1 year	2) all-cause mortality, hospitalization for heart failure progression, stroke, heart transplantation

Trial Locations

Locations (1)

Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine; 🇰🇷 Seoul, Korea, Republic of